BTLA and HVEM Cross Talk Regulates Inhibition and Costimulation

Advances in Immunology

Volumn 92, Issue , 2006, Pages 157-185

  Gavrieli, Maya ^a   Sedy, John ^a   Nelson, Christopher A ^a   Murphy, Kenneth M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B AND T LYMPHOCYTE ATTENUATOR; B7 PROTEIN; B7X PROTEIN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HERPESVIRUS ENTRY MEDIATOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN RECEPTOR; LIGAND; PROTEIN DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR;

B LYMPHOCYTE; CELL INTERACTION; CELL LINE; DISEASE PREDISPOSITION; HUMAN; INHIBITION KINETICS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; RECEPTOR CROSS-TALK; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; T-LYMPHOCYTES;

EID: 34547695667     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(06)92004-5     Document Type: Review

References (105)

1. Alegre M.L., Frauwirth K.A., and Thompson C.B. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1 (2001) 220-228
2. Banner D.W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.J., Broger C., Loetscher H., and Lesslauer W. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation. Cell 73 (1993) 431-445
3. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., and Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
4. Baroja M.L., Vijayakrishnan L., Bettelli E., Darlington P.J., Chau T.A., Ling V., Collins M., Carreno B.M., Madrenas J., and Kuchroo V.K. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 168 (2002) 5070-5078
5. Benedict C.A., Butrovich K.D., Lurain N.S., Corbeil J., Rooney I., Schneider P., Tschopp J., and Ware C.F. Cutting edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J. Immunol. 162 (1999) 6967-6970
6. Bodmer J.L., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27 (2002) 19-26
7. Boudreau R.T., and Hoskin D.W. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: Lessons from the mast cell model system. Int. Immunopharmacol. 5 (2005) 1507-1518
8. Bradshaw J.D., Lu P., Leytze G., Rodgers J., Schieven G.L., Bennett K.L., Linsley P.S., and Kurtz S.E. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry 36 (1997) 15975-15982
9. Campadelli-Fiume G., Cocchi F., Menotti L., and Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 10 (2000) 305-319
10. Carfi A., Willis S.H., Whitbeck J.C., Krummenacher C., Cohen G.H., Eisenberg R.J., and Wiley D.C. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell 8 (2001) 169-179
11. Chadha S., Miller K., Farwell L., Sacks S., Daly M.J., Rioux J.D., and Vyse T.J. Haplotype analysis of tumour necrosis factor receptor genes in 1p36: No evidence for association with systemic lupus erythematosus. Eur. J. Hum. Genet. 14 (2006) 69-78
12. Chemnitz J.M., Parry R.V., Nichols K.E., June C.H., and Riley J.L. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173 (2004) 945-954
13. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4 (2004) 336-347
14. Cheung T.C., Humphreys I.R., Potter K.G., Norris P.S., Shumway H.M., Tran B.R., Patterson G., Jean-Jacques R., Yoon M., Spear P.G., Murphy K.M., Lurain N.S., et al. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc. Natl. Acad. Sci. USA 102 (2005) 13218-13223
15. Chuang E., Lee K.M., Robbins M.D., Duerr J.M., Alegre M.L., Hambor J.E., Neveu M.J., Bluestone J.A., and Thompson C.B. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J. Immunol. 162 (1999) 1270-1277
16. Chuang E., Fisher T.S., Morgan R.W., Robbins M.D., Duerr J.M., Vander Heiden M.G., Gardner J.P., Hambor J.E., Neveu M.J., and Thompson C.B. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13 (2000) 313-322
17. Compaan D.M., Gonzalez L.C., Tom I., Loyet K.M., Eaton D., and Hymowitz S.G. Attenuating lymphocyte activity: The crystal structure of the BTLA-HVEM complex. J. Biol. Chem. 280 (2005) 39553-39561
18. Croft M. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity?. Nat. Rev. Immunol. 3 (2003) 609-620
19. Deppong C., Juehne T.I., Hurchla M., Friend L.D., Shah D.D., Rose C.M., Bricker T.L., Shornick L.P., Crouch E.C., Murphy T.L., Holtzman M.J., Murphy K.M., et al. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J. Immunol. 176 (2006) 3909-3913
20. Duhen T., Pasero C., Mallet F., Barbarat B., Olive D., and Costello R.T. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation. Eur. J. Immunol. 34 (2004) 3534-3541
21. Fan Z., Yu P., Wang Y., Fu M.L., Liu W., Sun Y., and Fu Y.X. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 107 (2006) 1342-1351
22. Force W.R., Walter B.N., Hession C., Tizard R., Kozak C.A., Browning J.L., and Ware C.F. Mouse lymphotoxin-beta receptor: Molecular genetics, ligand binding, and expression. J. Immunol. 155 (1995) 5280-5288
23. Frauwirth K.A., and Thompson C.B. Regulation of T lymphocyte metabolism. J. Immunol. 172 (2004) 4661-4665
24. Gavrieli M., and Murphy K.M. Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA. Biochem. Biophys. Res. Commun. 345 (2006) 1440-1445
25. Gavrieli M., Watanabe N., Loftin S.K., Murphy T.L., and Murphy K.M. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem. Biophys. Res. Commun. 312 (2003) 1236-1243
26. Gonzalez L.C., Loyet K.M., Calemine-Fenaux J., Chauhan V., Wranik B., Ouyang W., and Eaton D.L. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. USA 102 (2005) 1116-1121
27. Gough S.C., Walker L.S., and Sansom D.M. CTLA4 gene polymorphism and autoimmunity. Immunol. Rev. 204 (2005) 102-115
28. Granger S.W., and Rickert S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev. 14 (2003) 289-296
29. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
30. Guntermann C., and Alexander D.R. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: A potential role for tyrosine phosphatases. J. Immunol. 168 (2002) 4420-4429
31. Han P., Goularte O.D., Rufner K., Wilkinson B., and Kaye J. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172 (2004) 5931-5939
32. Harrop J.A., McDonnell P.C., Brigham-Burke M., Lyn S.D., Minton J., Tan K.B., Dede K., Spampanato J., Silverman C., Hensley P., DiPrinzio R., Emery J.G., et al. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J. Biol. Chem. 273 (1998) 27548-27556
33. Harrop J.A., Reddy M., Dede K., Brigham-Burke M., Lyn S., Tan K.B., Silverman C., Eichman C., DiPrinzio R., Spampanato J., Porter T., Holmes S., et al. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J. Immunol. 161 (1998) 1786-1794
34. Hsu H., Solovyev I., Colombero A., Elliott R., Kelley M., and Boyle W.J. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J. Biol. Chem. 272 (1997) 13471-13474
35. Hurchla M.A., Sedy J.R., Gavrielli M., Drake C.G., Murphy T.L., and Murphy K.M. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4(+) T cells. J. Immunol. 174 (2005) 3377-3385
36. Jackson D.E., Kupcho K.R., and Newman P.J. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J. Biol. Chem. 272 (1997) 24868-24875
37. Kirchner S., Boldt S., Kolch W., Haffner S., Kazak S., Janosch P., Holler E., Andreesen R., and Eissner G. LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway. J. Leukoc. Biol. 75 (2004) 324-331
38. Krieg C., Han P., Stone R., Goularte O.D., and Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J. Immunol. 175 (2005) 6420-6427
39. Krummenacher C., Supekar V.M., Whitbeck J.C., Lazear E., Connolly S.A., Eisenberg R.J., Cohen G.H., Wiley D.C., and Carfi A. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO J. 24 (2005) 4144-4153
40. Kwon B.S., Tan K.B., Ni J., Oh K.O., Lee Z.H., Kim K.K., Kim Y.J., Wang S., Gentz R., Yu G.L., Harrop J., Lyn S.D., et al. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272 (1997) 14272-14276
41. La S., Kim J., Kwon B.S., and Kwon B. Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation. Mol. Cells 14 (2002) 398-403
42. Langstein J., Michel J., Fritsche J., Kreutz M., Andreesen R., and Schwarz H. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160 (1998) 2488-2494
43. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., et al. PD-L2 is a second ligand for PD-I and inhibits T cell activation. Nature 2 (2001) 261-268
44. Lee K.M., Chuang E., Griffin M., Khattri R., Hong D.K., Zhang W., Straus D., Samelson L.E., Thompson C.B., and Bluestone J.A. Molecular basis of T cell inactivation by CTLA-4. Science 282 (1998) 2263-2266
45. Liu J., Schmidt C.S., Zhao F., Okragly A.J., Glasebrook A., Fox N., Galbreath E., Zhang Q., Song H.Y., Na S., and Yang D.D. LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function. Int. Immunol. 15 (2003) 861-870
46. Marengere L.E., Waterhouse P., Duncan G.S., Mittrucker H.W., Feng G.S., and Mak T.W. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272 (1996) 1170-1173
47. Marsters S.A., Ayres T.M., Skubatch M., Gray C.L., Rothe M., and Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J. Biol. Chem. 272 (1997) 14029-14032
48. Mauri D.N., Ebner R., Montgomery R.I., Kochel K.D., Cheung T.C., Yu G.L., Ruben S., Murphy M., Eisenberg R.J., Cohen G.H., Spear P.G., and Ware C.F. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8 (1998) 21-30
49. Miyatake S., Nakaseko C., Umemori H., Yamamoto T., and Saito T. Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152). Biochem. Biophys. Res. Commun. 249 (1998) 444-448
50. Montgomery R.I., Warner M.S., Lum B.J., and Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87 (1996) 427-436
51. Morel Y., Schiano de Colella J.M., Harrop J., Deen K.C., Holmes S.D., Wattam T.A., Khandekar S.S., Truneh A., Sweet R.W., Gastaut J.A., Olive D., and Costello R.T. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J. Immunol. 165 (2000) 4397-4404
52. Morel Y., Truneh A., Sweet R.W., Olive D., and Costello R.T. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 167 (2001) 2479-2486
53. Murphy M., Walter B.N., Pike-Nobile L., Fanger N.A., Guyre P.M., Browning J.L., Ware C.F., and Epstein L.B. Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ. 5 (1998) 497-505
54. Nakaseko C., Miyatake S., Iida T., Hara S., Abe R., Ohno H., Saito Y., and Saito T. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 190 (1999) 765-774
55. Okazaki T., and Wang J. PD-1/PD-L pathway and autoimmunity. Autoimmunity 38 (2005) 353-357
56. Okazaki T., Maeda A., Nishimura H., Kurosaki T., and Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 98 (2001) 13866-13871
57. Okkenhaug K., and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3 (2003) 317-330
58. Otsuki N., Kamimura Y., Hashiguchi M., and Azuma M. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochem. Biophys. Res. Commun. 344 (2006) 1121-1127
59. Parry R.V., Chemnitz J.M., Frauwirth K.A., Lanfranco A.R., Braunstein I., Kobayashi S.V., Linsley P.S., Thompson C.B., and Riley J.L. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25 (2005) 9543-9553
60. Riley J.L., and June C.H. The CD28 family: A T-cell rheostat for therapeutic control of T-cell activation. Blood 105 (2005) 13-21
61. Ronnstrand L., Arvidsson A.K., Kallin A., Rorsman C., Hellman U., Engstrom U., Wernstedt C., and Heldin C.H. SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis. Oncogene 18 (1999) 3696-3702
62. Rooney I.A., Butrovich K.D., Glass A.A., Borboroglu S., Benedict C.A., Whitbeck J.C., Cohen G.H., Eisenberg R.J., and Ware C.F. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J. Biol. Chem. 275 (2000) 14307-14315
63. Rudd C.E., and Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3 (2003) 544-556
64. Sarrias M.R., Whitbeck J.C., Rooney I., Ware C.F., Eisenberg R.J., Cohen G.H., and Lambris J.D. The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA. Mol. Immunol. 37 (2000) 665-673
65. Scheu S., Alferink J., Potzel T., Barchet W., Kalinke U., and Pfeffer K. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J. Exp. Med. 195 (2002) 1613-1624
66. Schneider H., and Rudd C.E. Tyrosine phosphatase SHP-2 binding to CTLA-4: Absence of direct YVKM/YFIP motif recognition. Biochem. Biophys. Res. Commun. 269 (2000) 279-283
67. Schneider H., da Rocha D.S., Hu H., and Rudd C.E. A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling. Eur. J. Immunol. 31 (2001) 2042-2050
68. Schwartz J.C., Zhang X., Fedorov A.A., Nathenson S.G., and Almo S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410 (2001) 604-608
69. Sedy J.R., Gavrieli M., Potter K.G., Hurchla M.A., Lindsley R.C., Hildner K., Scheu S., Pfeffer K., Ware C.F., Murphy T.L., and Murphy K.M. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6 (2005) 90-98
70. Shaikh R.B., Santee S., Granger S.W., Butrovich K., Cheung T., Kronenberg M., Cheroutre H., and Ware C.F. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J. Immunol. 167 (2001) 6330-6337
71. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily [Review]. Nat. Rev. Immunol. 2 (2002) 116-126
72. Sheppard K.A., Fitz L.J., Lee J.M., Benander C., George J.A., Wooters J., Qiu Y., Jussif J.M., Carter L.L., Wood C.R., and Chaudhary D. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett. 574 (2004) 37-41
73. Shi G., Luo H., Wan X., Salcedo T.W., Zhang J., and Wu J. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100 (2002) 3279-3286
74. Shiratori T., Miyatake S., Ohno H., Nakaseko C., Isono K., Bonifacino J.S., and Saito T. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6 (1997) 583-589
75. Smith C.A., Farrah T., and Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76 (1994) 959-962
76. Spear P.G., and Longnecker R. Herpesvirus entry: An update. J. Virol. 77 (2003) 10179-10185
77. Stamper C.C., Zhang Y., Tobin J.F., Erbe D.V., Ikemizu S., Davis S.J., Stahl M., Seehra J., Somers W.S., and Mosyak L. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410 (2001) 608-611
78. Stuber E., Neurath M., Calderhead D., Fell H.P., and Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2 (1995) 507-521
79. Suzuki I., and Fink P.J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187 (1998) 123-128
80. Tamada K., Shimozaki K., Chapoval A.I., Zhai Y., Su J., Chen S.F., Hsieh S.L., Nagata S., Ni J., and Chen L. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164 (2000) 4105-4110
81. Tamada K., Shimozaki K., Chapoval A.I., Zhu G., Sica G., Flies D., Boone T., Hsu H., Fu Y.X., Nagata S., Ni J., and Chen L. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 6 (2000) 283-289
82. Tamada K., Ni J., Zhu G., Fiscella M., Teng B., van Deursen J.M., and Chen L. Cutting edge: Selective impairment of CD8+ T cell function in mice lacking the TNF superfamily member LIGHT. J. Immunol. 168 (2002) 4832-4835
83. Tao R., Wang L., Han R., Wang T., Ye Q., Honjo T., Murphy T.L., Murphy K.M., and Hancock W.W. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J. Immunol. 175 (2005) 5774-5782
84. Teft W.A., Kirchhof M.G., and Madrenas J. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24 (2006) 65-97
85. van Essen D., Kikutani H., and Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378 (1995) 620-623
86. Wan X., Zhang J., Luo H., Shi G., Kapnik E., Kim S., Kanakaraj P., and Wu J. A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169 (2002) 6813-6821
87. Wang J., and Fu Y.X. LIGHT (a cellular ligand for herpes virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion is dependent on the interaction between TCR and MHC/self-peptide. J. Immunol. 170 (2003) 3986-3993
88. Wang J., Auger K.R., Jarvis L., Shi Y., and Roberts T.M. Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 270 (1995) 12774-12780
89. Wang J., Chun T., Lo J.C., Wu Q., Wang Y., Foster A., Roca K., Chen M., Tamada K., Chen L., Wang C.R., and Fu Y.X. The critical role of LIGHT, a TNF family member, in T cell development. J. Immunol. 167 (2001) 5099-5105
90. Wang J., Lo J.C., Foster A., Yu P., Chen H.M., Wang Y., Tamada K., Chen L., and Fu Y.X. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J. Clin. Invest. 108 (2001) 1771-1780
91. Wang J., Anders R.A., Wu Q., Peng D., Cho J.H., Sun Y., Karaliukas R., Kang H.S., Turner J.R., and Fu Y.X. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J. Clin. Invest. 113 (2004) 826-835
92. Wang Y., Subudhi S.K., Anders R.A., Lo J., Sun Y., Blink S., Wang Y., Wang J., Liu X., Mink K., Degrandi D., Pfeffer K., et al. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J. Clin. Invest. 115 (2005) 711-717
93. Wang Y.G., Kim K.D., Wang J., Yu P., and Fu Y.X. Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion. J. Immunol. 175 (2005) 6997-7002
94. Watanabe N., Gavrieli M., Sedy J.R., Yang J., Fallarino F., Loftin S.K., Hurchla M.A., Zimmerman N., Sim J., Zang X., Murphy T.L., Russell J.H., et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4 (2003) 670-679
95. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23 (2005) 23-68
96. Whitbeck J.C., Connolly S.A., Willis S.H., Hou W., Krummenacher C., Lou D.L., Ponce H., Baribaud I., Eisenberg R.J., and Cohen G.H. Localization of the gD-binding region of the human herpes simplex virus receptor, HveA. J. Virol. 75 (2001) 171-180
97. Wiley S.R., Goodwin R.G., and Smith C.A. Reverse signaling via CD30 ligand. J. Immunol. 157 (1996) 3635-3639
98. Wu Q., Wang Y., Wang J., Hedgeman E.O., Browning J.L., and Fu Y.X. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 190 (1999) 629-638
99. Ye Q., Fraser C.C., Gao W., Wang L., Busfield S.J., Wang C., Qiu Y., Coyle A.J., Gutierrez-Ramos J.C., and Hancock W.W. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J. Exp. Med. 195 (2002) 795-800
100. Yi L.A., Hajialiasgar S., and Chuang E. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo. Int. Immunol. 16 (2004) 539-547
101. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., and Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274 (1999) 13733-13736
102. Yu P., Lee Y., Liu W., Chin R.K., Wang J., Wang Y., Schietinger A., Philip M., Schreiber H., and Fu Y.X. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat. Immunol. 5 (2004) 141-149
103. Zhai Y., Guo R., Hsu T.L., Yu G.L., Ni J., Kwon B.S., Jiang G.W., Lu J., Tan J., Ugustus M., Carter K., Rojas L., et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 102 (1998) 1142-1151
104. Zhang X., Schwartz J.C., Guo X., Bhatia S., Cao E., Lorenz M., Cammer M., Chen L., Zhang Z.Y., Edidin M.A., Nathenson S.G., and Almo S.C. Structural and functional analysis of the costimulatory receptor programed death-1. Immunity 20 (2004) 337-347
105. Zhang Y., and Allison J.P. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc. Natl. Acad. Sci. USA 94 (1997) 9273-9278